The role of muscle biopsy in the diagnosis of inflammatory myopathy

Sakir Gultekin

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Muscle biopsies of patients with immune-mediated inflammatory myopathies are characterized by a combination of chronic inflammatory infiltrates and muscle fiber necrosis. In addition, there are typical histochemical, immunohistochemical, and ultrastructural findings of each type of inflammatory myopathy. Accurate classification of inflammatory myopathies is important because inclusion body myositis does not respond to immunosuppressive treatment, polymyositis is frequently part of an overlap syndrome, and dermatomyositis is associated with cancer in adults. Necrotizing myopathy without inflammation may be due to a partially treated inflammatory myopathy, a toxic myopathy, or a paraneoplastic myopathy. Metabolic myopathies and muscular dystrophies may clinically and rarely pathologically mimic inflammatory myopathy. Correct identification of these entities depends on better awareness of clinical similarities between metabolic myopathy and inflammatory myopathy; appropriate utilization of immunohistochemical, ultrastructural, biochemical, and genetic techniques on muscle samples in difficult cases; and maximizing communication between the clinician and the pathologist.

Original languageEnglish (US)
Title of host publicationtThe Inflammatory Myopathies
PublisherHumana Press
Pages95-110
Number of pages16
ISBN (Print)9781603278287
DOIs
StatePublished - 2009

Fingerprint

Myositis
Muscular Diseases
Biopsy
Muscles
Inclusion Body Myositis
Genetic Techniques
Polymyositis
Dermatomyositis
Muscular Dystrophies
Poisons
Immunosuppressive Agents
Molecular Biology
Necrosis
Communication
Inflammation
Neoplasms

Keywords

  • Dysferlin
  • Glycogen storage disease
  • Inclusion body myositis
  • Limb-girdle
  • Mitochondrial myopathy
  • Muscular dystrophy
  • Statin myopathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gultekin, S. (2009). The role of muscle biopsy in the diagnosis of inflammatory myopathy. In tThe Inflammatory Myopathies (pp. 95-110). Humana Press. https://doi.org/10.1007/978-1-60327-827-0_6

The role of muscle biopsy in the diagnosis of inflammatory myopathy. / Gultekin, Sakir.

tThe Inflammatory Myopathies. Humana Press, 2009. p. 95-110.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gultekin, S 2009, The role of muscle biopsy in the diagnosis of inflammatory myopathy. in tThe Inflammatory Myopathies. Humana Press, pp. 95-110. https://doi.org/10.1007/978-1-60327-827-0_6
Gultekin S. The role of muscle biopsy in the diagnosis of inflammatory myopathy. In tThe Inflammatory Myopathies. Humana Press. 2009. p. 95-110 https://doi.org/10.1007/978-1-60327-827-0_6
Gultekin, Sakir. / The role of muscle biopsy in the diagnosis of inflammatory myopathy. tThe Inflammatory Myopathies. Humana Press, 2009. pp. 95-110
@inbook{2cb10bf397784d48a97087f2cc26afd6,
title = "The role of muscle biopsy in the diagnosis of inflammatory myopathy",
abstract = "Muscle biopsies of patients with immune-mediated inflammatory myopathies are characterized by a combination of chronic inflammatory infiltrates and muscle fiber necrosis. In addition, there are typical histochemical, immunohistochemical, and ultrastructural findings of each type of inflammatory myopathy. Accurate classification of inflammatory myopathies is important because inclusion body myositis does not respond to immunosuppressive treatment, polymyositis is frequently part of an overlap syndrome, and dermatomyositis is associated with cancer in adults. Necrotizing myopathy without inflammation may be due to a partially treated inflammatory myopathy, a toxic myopathy, or a paraneoplastic myopathy. Metabolic myopathies and muscular dystrophies may clinically and rarely pathologically mimic inflammatory myopathy. Correct identification of these entities depends on better awareness of clinical similarities between metabolic myopathy and inflammatory myopathy; appropriate utilization of immunohistochemical, ultrastructural, biochemical, and genetic techniques on muscle samples in difficult cases; and maximizing communication between the clinician and the pathologist.",
keywords = "Dysferlin, Glycogen storage disease, Inclusion body myositis, Limb-girdle, Mitochondrial myopathy, Muscular dystrophy, Statin myopathy",
author = "Sakir Gultekin",
year = "2009",
doi = "10.1007/978-1-60327-827-0_6",
language = "English (US)",
isbn = "9781603278287",
pages = "95--110",
booktitle = "tThe Inflammatory Myopathies",
publisher = "Humana Press",

}

TY - CHAP

T1 - The role of muscle biopsy in the diagnosis of inflammatory myopathy

AU - Gultekin, Sakir

PY - 2009

Y1 - 2009

N2 - Muscle biopsies of patients with immune-mediated inflammatory myopathies are characterized by a combination of chronic inflammatory infiltrates and muscle fiber necrosis. In addition, there are typical histochemical, immunohistochemical, and ultrastructural findings of each type of inflammatory myopathy. Accurate classification of inflammatory myopathies is important because inclusion body myositis does not respond to immunosuppressive treatment, polymyositis is frequently part of an overlap syndrome, and dermatomyositis is associated with cancer in adults. Necrotizing myopathy without inflammation may be due to a partially treated inflammatory myopathy, a toxic myopathy, or a paraneoplastic myopathy. Metabolic myopathies and muscular dystrophies may clinically and rarely pathologically mimic inflammatory myopathy. Correct identification of these entities depends on better awareness of clinical similarities between metabolic myopathy and inflammatory myopathy; appropriate utilization of immunohistochemical, ultrastructural, biochemical, and genetic techniques on muscle samples in difficult cases; and maximizing communication between the clinician and the pathologist.

AB - Muscle biopsies of patients with immune-mediated inflammatory myopathies are characterized by a combination of chronic inflammatory infiltrates and muscle fiber necrosis. In addition, there are typical histochemical, immunohistochemical, and ultrastructural findings of each type of inflammatory myopathy. Accurate classification of inflammatory myopathies is important because inclusion body myositis does not respond to immunosuppressive treatment, polymyositis is frequently part of an overlap syndrome, and dermatomyositis is associated with cancer in adults. Necrotizing myopathy without inflammation may be due to a partially treated inflammatory myopathy, a toxic myopathy, or a paraneoplastic myopathy. Metabolic myopathies and muscular dystrophies may clinically and rarely pathologically mimic inflammatory myopathy. Correct identification of these entities depends on better awareness of clinical similarities between metabolic myopathy and inflammatory myopathy; appropriate utilization of immunohistochemical, ultrastructural, biochemical, and genetic techniques on muscle samples in difficult cases; and maximizing communication between the clinician and the pathologist.

KW - Dysferlin

KW - Glycogen storage disease

KW - Inclusion body myositis

KW - Limb-girdle

KW - Mitochondrial myopathy

KW - Muscular dystrophy

KW - Statin myopathy

UR - http://www.scopus.com/inward/record.url?scp=84892193672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892193672&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-827-0_6

DO - 10.1007/978-1-60327-827-0_6

M3 - Chapter

AN - SCOPUS:84892193672

SN - 9781603278287

SP - 95

EP - 110

BT - tThe Inflammatory Myopathies

PB - Humana Press

ER -